Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism

Abstract

Abstract. In a previous study, generally lower drug release rates from RL:L55 blend coated pellets in neutral/basic release media than in acidic release media were reported. The aim of this study was to obtain information on the drug release mechanism of solid dosage forms coated with blends of Eudragit ® RL (RL) and Eudragit ® L-55 (L55). Swelling experiments with free films were analyzed spectroscopically and gravimetrically to identify the physicochemical cause for this release behavior. With Raman spectroscopy, the swelling of copolymer films could be monitored. IR spectroscopic investigations on RL:L55 blends immersed in media at pH 6.8 confirmed the formation of interpolyelectrolyte complexes (IPECs) that were not detectable after swelling in hydrochloric acid pH 1.2. Further investigations revealed that these IPECs decreased the extent of ion exchange between the quaternary ammonium groups of RL and the swelling media. This is presumably the reason for the previously reported decreased drug permeability of RL:L55 coatings in neutral/basic media as ion exchange is the determining factor in drug release from RL coated dosage forms. Gravimetric erosion studies confirmed that L55 was not leached out of the film blends during swelling in phosphate buffer pH 6.8. In contrast to all other investigated films, the 4:1 (RL:L55) blend showed an extensive swelling within 24 h at pH 6.8 which explains the reported sigmoidal release behavior of 4:1 blend coated pellets. These results help to understand the release behavior of RL:L55 blend coated solid dosage forms.KEY WORDS: enteric polymethacrylate; interpolyelectrolyte complex; ion exchange; polymer blend; quaternary polymethacrylate.

Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers

“…These results could be explained by Eu, a pH-sensitive polymer, is not dissolved in acidic condition. Therefore, it is capable of protecting the drug being degraded in the stomach (Sauer & McGinity, 2009 ; Wulff & Leopold, 2016 ). Eu has been successfully used for increasing the therapeutic effects of many drugs substances, such as curcumin, insulin, and omeprazole (Li et al., 2006 ; Hao et al., 2013 ; Manconi et al., 2019 ).…”

Janus microspheres for enhanced enteral drug delivery: Preparation and orientated attachment to a Caco-2 monolayer

“…The exchange of the quaternary ammonium group counterions with the surrounding medium develops a water flux within which drug molecules can diffuse out of the dosage form (31). The attraction of ions in the release medium to the quaternary ammonium groups determines the extent of water flux and hence the drug release rate (32). In addition, the contribution of the interaction between ammonioalkyl methacrylate copolymer and FD4, which are cationic and anionic, respectively, at pH 6.8 in the dissolution test, has to be taken into consideration.…”

Application of Quality by Design Principles for Optimizing Process Variables of Extrusion and Spheronization of a Captopril Pellet Formulation

“…The Pareto plot depicted in fig. 2B reveals that variables such as drying and mixing times have an antagonistic effect on the cumulative % CP released at 0.5 h. This effect can be explained due to decreased dissolution of CP from pellets as a consequence of reduced porosity within the pellet that retards entry of the dissolution medium into the core of the pellet [19] . The data in the Pareto plot suggests that an increase in the volume of ERL used, results in a significant decrease in the cumulative % CP released at 0.5 h. In addition the use of ERL may result in the formation of a matrix in the core that on increasing the amount of liquid used, results in the manufacture of dense, hard pellets that exhibit slow release.…”